Clinical outcomes associated with re-excision after unplanned excision or re-excision after local recurrence in patients with nonmetastatic synovial sarcoma

Author:

Zhang Hongqiang1,Sun Wei2,Huang Wending2,Yan Wangjun2,Wang Hongbo1,Qu Guolun1,Wang Kangwei1,Shang Changquan1,Qu Xinglong1,Wang Chunmeng2,Chen Yong2

Affiliation:

1. Fudan University Shanghai Cancer Center Minhang Branch Hospital

2. Fudan University Shanghai Cancer Center

Abstract

Abstract Background: The unplanned excision of synovial sarcomas in centers that do not specialize in sarcoma treatment necessitates extensive wide re-excision to maintain adequate margins. The present study was developed to examine the efficacy in SS patients with and without residual tumor tissue following unplanned surgical excision, and to compare differences in prognostic outcomes between individuals with residual tumor tissue and those that experienced local recurrence. Method: Synovial sarcoma patients that underwent re-excision in our center between 2009 and 2019 were included in unplanned excision and local recurrence groups, with patients in the unplanned excision group being further stratified into those with and without residual tumor tissue. Analyzed endpoints included overall survival (OS), local recurrence-free survival (LRFS), and distant relapse-free survival (DRFS). Prognostic factors associated with these three different survival outcomes were analyzed through the use of Kaplan-Meier curves and Cox regression approaches. Result: In total, this study incorporated 121 synovial sarcoma patients (68 female, 53 male; median age: 36 years), including 33 (27.3%) with no residual tumor tissue, 31 (25.6%) with residual tumor tissue, and 57 (47.1%) in the local recurrence group. Patients were assessed over a median 51-month follow-up period. The respective median intervals to definitive surgery in the unplanned excision and local recurrence groups were 35 days and 60 days. The respective 5-year OS, 5-year LRFS, and 5-year DRFS were 76.9%, 80.6%, and 59.6% for the non-residual group, 73.0%, 80.4%, and Not Available (NA) for the residual tumor tissue group, and 75.2%, 77.3%, and NA in the local recurrence group. Conclusion: In synovial sarcoma patients with positive margins or residual tumor tissue following unplanned surgical excision, re-excision procedures can yield improved local control and OS to levels similar to those observed in patients without residual tumor. Relative to patients with local recurrence, significantly improved local control and OS are observed for patients with residual tumor following immediate extensive R0 resection. These results thus suggest that following initial incomplete tumor excision, patients should be promptly transferred to centers specializing in the treatment of sarcomas for adequate re-excision.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Synovial sarcoma. An Analysis of 134 Tumors;Cadman NL;Cancer,1965

2. Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review;Riedel RF;Cancers (Basel),2018

3. Clinical Significance and Risk Factors of Local Recurrence in Synovial Sarcoma: A Retrospective Analysis of 171 Cases;Zhang HQ;Front Surg,2022

4. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma;Singer S;Ann Surg,1994

5. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3